Cabot Small-Cap Confidential Weekly Update
With earnings season largely over most of our stocks are now moving based on news that affects the broad market, and less on company-specific trends, with a few exceptions.
Read More
market correction
Read More
market correction Archives
Cabot Top Ten Trader Movers & Shakers Weekly Update
The market was mostly quiet (though also mostly positive) for the first four days of the week, though volatility picked up today after some additional tariffs from China and Fed Chair Jerome Powell’s speech in Wyoming.
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
A Spanish news outlet, Intereconomia.com, is reporting that biotech company Amgen (AMGN) is in talks to buy Alexion Pharmaceuticals (ALXN) for close to $200 per share.
Read More
Current Market Update
From Cabot Top Ten Trader
Despite all the moves of the past couple of weeks and today’s headlines, nothing has really changed with our overall view. Looking at the primary evidence, the market’s intermediate-term trend has yet to turn positive—all major indexes continue to around...
Read More
Cabot Growth Investor Bi-weekly Update
Remain generally cautious given that our Cabot Tides are still negative, though you shouldn’t be outright defensive given the encouraging action from so many growth stocks.
Read More
Cabot Global Stocks Explorer 692
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Cabot Dividend Investor Weekly Update
The market seems to be rebounding and stabilizing after a tumultuous couple of weeks. The escalation of trade tensions, a sputtering global economy and talk of the next recession spooked investors. But as fear wanes investors realize that money has no place else go...
Read More
Cabot Stock of the Week 261
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
Today’s and next week’s issues of Cabot Undervalued Stocks Advisor are going to look a bit different. I won’t be reviewing all of our portfolio stocks today. Many Wall Street analysts are on vacation, so there will be very little in the way changes...
Read More
Cabot Prime Pro Week Ending August 23, 2019
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Prime Week Ending August 23, 2019
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Small-Cap Confidential Weekly Update
The big news that affected the market this week was, of course, the dreaded yield curve inversion. This happens when the 10-year Treasury yield goes below the 2-year yield.
Read More
Cabot Top Ten Trader Movers & Shakers Weekly Update
It’s been a mostly sour week, with the S&P 500 and Nasdaq down 1.5% to 2% even after this morning's gap up, and small-cap indexes down a bit more than that. Most indexes are testing their lows from last Monday, and the intermediate-term continues...
Read More
In a News-Driven Stock Market, You Need to Play Defense
News has been driving the stock market more than usual this year. Lately, that hasn't been a good thing. Here's how to defend your portfolio from bad press.
Read More
Cabot Growth Investor Special Bulletin
The market enjoyed a couple rounds of decent buying during the past week, but today brought a huge round of selling as the headlines blared about the inverted yield curve.
Read More
Cabot Marijuana Investor Update
Yesterday’s strong market triggered a technical indicator, a follow-through signal that tells us buyers are lurking. Of course, today’s big decline so far isn’t good to see, but nevertheless, this and other measures (awful sentiment, etc.) tell us there should be support on weakness.
Read More
Cabot Growth Investor 1426
Play Some Defense
Usually, when the market is doing well, stocks aren’t affected much by the news of the day. That’s not to say individual stocks don’t get pushed around, but for the market as a whole, worrisome headline news usually goes the way water...
Read More
Apple vs. Amazon Stock: Which Is the Better Buy?
Apple and Amazon are two of the most recognizable names on the planet, and good stocks. Which is the better buy? Let's break down Amazon vs. Apple stock.
Read More
Cabot Dividend Investor Weekly Update
This week is a still familiar story in the portfolio, with defensive stocks thriving and moving still higher.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
U.S. stock markets have exhibited a high degree of volatility in recent weeks. There are lots of factors contributing to the turmoil, which will ebb and flow, probably for the rest of our lives. So let’s just circle back to why we’re here: here...
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up